Rani Therapeutics Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 0.6054 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 84.39M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in prec...